Furthermore, our findings extend the current understanding of the kinase activity of ROCK1 without affecting cellular cytoskeleton and identify a novel mechanism underlying ROCK1-mediated ERK phosphorylation and activation due to CLU loss during lung cancer progression. This evidence concerns the gene CLU and lung carcinoma.